Bone Biologics Corp (BBLG) › Shareholders' EquityBone Biologics Corp (BBLG) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2007: -$9.7K2008: -$10.2K2009: -$20.5K2010: -$24.0K2011: -$29.0K2012: -$4.68M2013: -$5.61M2014: -$3.70M2015: -$4.20M2016: -$8.36M2017: -$8.40M2018: -$8.60M2019: -$11.87M2020: -$13.69M2021: $6.58M2022: $5.95M2023: $2.91M2024: $3.48M2025: $5.38M$5.38M2007Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$5.38M+54.4%2024$3.48M+19.9%2023$2.91M-51.1%2022$5.95M-9.6%2021$6.58M+148.0%2020-$13.69M-15.4%2019-$11.87M-38.0%2018-$8.60M-2.4%2017-$8.40M-0.4%2016-$8.36M-99.2%2015-$4.20M-13.5%2014-$3.70M+34.1%2013-$5.61M-19.9%2012-$4.68M-16042.9%2011-$29.0K-20.5%2010-$24.0K-17.6%2009-$20.5K-101.2%2008-$10.2K-4.6%2007-$9.7K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share